A ADMA BIOLOGICS INC
| Market Cap | $2.19B |
| P/E Ratio | 15.32 |
| Forward P/E | 6.66 |
| Dividend Yield | — |
| Beta | 0.82 |
| 52W Range | $8.29 - $24.51 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Biotechnology |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Terry Smith Fundsmith LLP | 0.22% | $38.34M | 2,102,054 | Buy |
Insider Trading
| Insider Name of the company insider who made the trade 17 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Grossman Adam SPresident and CEO | Sale | 6,000 | $15.16 | $90.96K | 16 Mar 2026 | 16 Mar 2026 |
| Grossman Adam SPresident and CEO | Sale | 15,000 | $15.16 | $227.40K | 16 Mar 2026 | 16 Mar 2026 |
| Kestenberg-Messina Kaitlin M.COO and SVP, Compliance | Sale | 10,096 | $15.63 | $157.80K | 09 Mar 2026 | 06 Mar 2026 |
| ELMS STEVE | Buy | 7,000 | $15.39 | $107.73K | 06 Mar 2026 | 05 Mar 2026 |
| ELMS STEVE | Buy | 7,000 | $15.67 | $109.69K | 05 Mar 2026 | 05 Mar 2026 |
| Grossman Adam SPresident and CEO | Sale | 6,000 | $16.08 | $96.48K | 17 Feb 2026 | 17 Feb 2026 |
| Grossman Adam SPresident and CEO | Sale | 15,000 | $16.08 | $241.20K | 17 Feb 2026 | 17 Feb 2026 |
| Grossman Adam SPresident and CEO | Sale | 15,000 | $19.79 | $296.85K | 15 Dec 2025 | 16 Dec 2025 |
| Grossman Adam SPresident and CEO | Sale | 6,000 | $19.79 | $118.74K | 15 Dec 2025 | 16 Dec 2025 |
| Grossman Adam SPresident and CEO | Sale | 6,000 | $16.00 | $96.00K | 19 Nov 2025 | 21 Nov 2025 |
| Grossman Adam SPresident and CEO | Sale | 15,000 | $16.00 | $240.00K | 19 Nov 2025 | 21 Nov 2025 |
| Adam S GrossmanPresident and CEO | Sale | 6,000 | $16.00 | $96.00K | 19 Nov 2025 | 21 Nov 2025 |
| Adam S GrossmanPresident and CEO | Sale | 15,000 | $16.00 | $240.00K | 19 Nov 2025 | 21 Nov 2025 |
| Grossman Adam SPresident and CEO | Sale | 15,000 | $16.00 | $240.00K | 24 Oct 2025 | 24 Oct 2025 |
| Grossman Adam SPresident and CEO | Sale | 6,000 | $16.00 | $96.00K | 24 Oct 2025 | 24 Oct 2025 |
| Adam S GrossmanPresident and CEO | Sale | 6,000 | $16.00 | $96.00K | 24 Oct 2025 | 24 Oct 2025 |
| Adam S GrossmanPresident and CEO | Sale | 15,000 | $16.00 | $240.00K | 24 Oct 2025 | 24 Oct 2025 |
Frequently Asked Questions
What is ADMA stock price today?
ADMA BIOLOGICS INC (ADMA) is currently trading at $9.19. The stock has a 52-week range of $8.29 to $24.51 and a market capitalization of $2.19B.
Is ADMA a good stock to buy in 2026?
ADMA BIOLOGICS INC has a P/E ratio of 15.3 (forward P/E: 6.7), a dividend yield of none, and 1-year performance of -52.8%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling ADMA stock?
There have been 17 insider transactions for ADMA in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has ADMA stock performed over the past year?
ADMA BIOLOGICS INC (ADMA) has returned -52.8% over the past 12 months. The stock traded between $8.29 and $24.51 during this period, and is currently at $9.19.
Which hedge funds own ADMA (ADMA BIOLOGICS INC)?
1 tracked hedge funds currently hold ADMA in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is ADMA's market cap and valuation?
ADMA BIOLOGICS INC (ADMA) has a market capitalization of $2.19B. The trailing P/E ratio is 15.3 and forward P/E is 6.7. The stock is classified in the Healthcare sector.
What is ADMA's revenue and profitability?
ADMA BIOLOGICS INC reported revenue of $510.17M with net income of $146.93M and a profit margin of 0.29%. The stock has a beta of 0.82.
What sector is ADMA in and who are its biggest institutional holders?
ADMA BIOLOGICS INC (ADMA) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.